These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1069309)

  • 1. Dichloromethane as an antisickling agent in sickle cell hemoglobin.
    Schoenborn BP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4195-9. PubMed ID: 1069309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dichloromethane on sickle cells. An in vitro water proton magnetic resonance relaxation study.
    Matthews RM; James TL
    Biochem Biophys Res Commun; 1978 Feb; 80(4):879-85. PubMed ID: 637872
    [No Abstract]   [Full Text] [Related]  

  • 3. A new antisickling agent: in vitro studies of its effect on S/S erythrocytes and on hemoglobin S.
    Adhikary PK; Haynes JK; Patthey HL; Rhodes RS
    Experientia; 1978 Jun; 34(6):804-6. PubMed ID: 658310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
    Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dichloromethane on the oxygenation of hemoglobin.
    Saxena AM; North BE; Schoenborn BP
    Biochim Biophys Acta; 1982 May; 704(1):1-6. PubMed ID: 7093282
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of erythrocyte sickling in vitro by pyridoxal.
    Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
    J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of sickled erythrocytes and of sickle-cell hemoglobin fibers.
    Finch JT; Perutz MF; Bertles JF; Döbler J
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):718-22. PubMed ID: 4123689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach to the treatment of sickle cell anemia.
    Milosz A; Settle W
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):137-46. PubMed ID: 1188180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological and x-ray studies of potential antisickling agents.
    Abraham DJ; Perutz MF; Phillips SE
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):324-8. PubMed ID: 6572894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl adipimidate: a new antisickling agent.
    Lubin BH; Pena V; Mentzer WC; Bymun E; Bradley TB; Packer L
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):43-6. PubMed ID: 1054514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dichloromethane on the sciatic motor conduction velocity of rats.
    Pankow D; Gutewort R; Ponsold W; Glatzel W; Tietze K
    Experientia; 1979 Mar; 35(3):373-4. PubMed ID: 446623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.
    Xu GG; Pagare PP; Ghatge MS; Safo RP; Gazi A; Chen Q; David T; Alabbas AB; Musayev FN; Venitz J; Zhang Y; Safo MK; Abdulmalik O
    Mol Pharm; 2017 Oct; 14(10):3499-3511. PubMed ID: 28858508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxygen transport capacity of the blood as modified by ethanol and dichloromethane].
    Pankow D; Ponsold W; Moritz RP
    Z Gesamte Hyg; 1985 Aug; 31(8):460-3. PubMed ID: 4060784
    [No Abstract]   [Full Text] [Related]  

  • 18. Sickle hemoglobin aggregation: a new class of inhibitors.
    Votano JR; Gorecki M; Rich A
    Science; 1977 Jun; 196(4295):1216-9. PubMed ID: 870976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of dichloromethane and ethanol in rats: toxicokinetics and nerve conduction velocity.
    Glatzel W; Tietze K; Gutewort R; Pankow D
    Alcohol Clin Exp Res; 1987 Oct; 11(5):450-2. PubMed ID: 3314558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand kinetics of hemoglobin S containing erythrocytes.
    Harrington JP; Elbaum D; Bookchin RM; Wittenberg JB; Nagel RL
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):203-6. PubMed ID: 264675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.